Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson’s disease

Clicks: 69
ID: 270552
2021
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #85 of 95 articles by views in acta neuropathologica communications

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Peripheral biomarkers indicative of brain pathology are critically needed for early detection of Parkinson’s disease (PD). In this study, using NanoString and digital PCR technologies, we began by screening for alterations in genes associated ...
Reference Key
zhang2021actareduced Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Xiaodan Liu, Qilong Wang, Ying Yang, Tessandra Stewart, Min Shi, David Soltys, Genliang Liu, Eric Thorland, Eugene M. Cilento, Yiran Hou, Zongran Liu, Tao Feng, Jing Zhang;Xiaodan Liu;Qilong Wang;Ying Yang;Tessandra Stewart;Min Shi;David Soltys;Genliang Liu;Eric Thorland;Eugene M. Cilento;Yiran Hou;Zongran Liu;Tao Feng;Jing Zhang;
Journal acta neuropathologica communications
Year 2021
DOI
10.1186/s40478-021-01133-6
URL
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941904/?report=reader
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.